Sensitivity and performance of three novel quantitative assays of SARS-CoV-2 nucleoprotein in blood

To assess if SARS-CoV-2 (COVID-19) systemic disease can be determined by available nucleoprotein assays, we compared the performance of three commercial SARS-CoV-2 nucleoprotein (N) assays in plasma. A total of 272 plasma samples collected in the period November–December 2021 were analyzed by the me...

Descripción completa

Detalles Bibliográficos
Autores principales: Hillig, Thore, Kristensen, Josephine R., Brasen, Claus L., Brandslund, Ivan, Olsen, Dorte A., Davidsen, Camilla, Madsen, Jonna S., Jensen, Claus A., Hansen, Young B. L., Friis-Hansen, Lennart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937528/
https://www.ncbi.nlm.nih.gov/pubmed/36806155
http://dx.doi.org/10.1038/s41598-023-29973-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937528/
https://www.ncbi.nlm.nih.gov/pubmed/36806155
http://dx.doi.org/10.1038/s41598-023-29973-3

Ejemplares similares